| # | Title | Journal | Year | Citations |
|---|
| 1 | Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement | European Heart Journal | 2022 | 290 |
| 2 | Predicting Cardiovascular Events in Familial Hypercholesterolemia | Circulation | 2017 | 270 |
| 3 | Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | New England Journal of Medicine | 2021 | 247 |
| 4 | The Role of Nutraceuticals in Statin Intolerant Patients | Journal of the American College of Cardiology | 2018 | 216 |
| 5 | Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study | Lancet Diabetes and Endocrinology,the | 2017 | 191 |
| 6 | Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM | Clinical Chemistry | 2018 | 189 |
| 7 | Effect of aerobic and resistance exercise training on vascular function in heart failure | American Journal of Physiology - Heart and Circulatory Physiology | 2000 | 184 |
| 8 | Optimizing Cholesterol Treatment in Patients With Muscle Complaints | Journal of the American College of Cardiology | 2017 | 162 |
| 9 | Exercise-induced improvement in endothelial dysfunction is not mediated by changes in CV risk factors: pooled analysis of diverse patient populations | American Journal of Physiology - Heart and Circulatory Physiology | 2003 | 140 |
| 10 | Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM | Atherosclerosis | 2020 | 137 |
| 11 | Assessment of brachial artery blood flow across the cardiac cycle: retrograde flows during cycle ergometry | Journal of Applied Physiology | 2002 | 121 |
| 12 | Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM | Clinical Chemistry and Laboratory Medicine | 2020 | 119 |
| 13 | Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs | Journal of Clinical Lipidology | 2017 | 105 |
| 14 | The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential | Cardiovascular Diabetology | 2019 | 104 |
| 15 | Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials | Pharmacological Research | 2019 | 90 |
| 16 | Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia | Journal of Clinical Lipidology | 2017 | 87 |
| 17 | Prognostic value of segment involvement score compared to other measures of coronary atherosclerosis by computed tomography: A systematic review and meta-analysis | Journal of Cardiovascular Computed Tomography | 2017 | 58 |
| 18 | Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study | American Heart Journal | 2019 | 53 |
| 19 | Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia | BMJ: British Medical Journal | 2003 | 50 |
| 20 | Active Length-Tension Relations Compared in Isometric, Afterloaded and Isotonic Contractions of Cat Papillary Muscle | Circulation Research | 1970 | 43 |
| 21 | Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial | Circulation | 2021 | 41 |
| 22 | Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone | Metabolism: Clinical and Experimental | 2020 | 40 |
| 23 | Assessing the evidence–practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics | European Journal of Heart Failure | 2020 | 38 |
| 24 | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text | Current Vascular Pharmacology | 2019 | 38 |
| 25 | Plasma platelet-activating factor degradation in patients with severe coronary artery disease | Clinical Science | 1992 | 33 |
| 26 | Left ventricular response to experimentally induced chronic aortic regurgitation | Cardiovascular Research | 1972 | 32 |
| 27 | Are the associations between diet and C-reactive protein independent of obesity? | Preventive Medicine | 2008 | 31 |
| 28 | Contractile Properties of Cardiac Muscle in Hyperthyroidism | Circulation Research | 1970 | 26 |
| 29 | Association between phenotypic familial hypercholesterolaemia and telomere length in US adults: results from a multi-ethnic survey | European Heart Journal | 2018 | 25 |
| 30 | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement | Current Vascular Pharmacology | 2019 | 23 |
| 31 | TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol | BMJ Open | 2018 | 19 |
| 32 | Lipid management in people with peripheral artery disease | Current Opinion in Lipidology | 2019 | 19 |
| 33 | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review | Current Vascular Pharmacology | 2019 | 19 |
| 34 | Cost-Effectiveness of Coronary Artery Calcium Scoring in People With a Family History of Coronary Disease | JACC: Cardiovascular Imaging | 2021 | 18 |
| 35 | Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy | Journal of Clinical Lipidology | 2019 | 16 |
| 36 | Radiofrequency catheter ablation of atrial tachycardia | Australian and New Zealand Journal of Medicine | 1995 | 15 |
| 37 | Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health | Frontiers in Psychiatry | 2016 | 15 |
| 38 | Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures | Heart Rhythm | 2021 | 15 |
| 39 | Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition? | European Heart Journal | 2016 | 14 |
| 40 | Rationale and design of a trial to personalize risk assessment in familial coronary artery disease | American Heart Journal | 2018 | 14 |
| 41 | Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol | American Heart Journal | 2021 | 14 |
| 42 | Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk | Journal of the American College of Cardiology | 2022 | 14 |
| 43 | Lipoprotein (a) and diabetes mellitus: causes and consequences | Current Opinion in Endocrinology, Diabetes and Obesity | 2021 | 13 |
| 44 | Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3 | Future Cardiology | 2022 | 13 |
| 45 | Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n-Dimensions (SHY-n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection | Analytical Chemistry | 2022 | 13 |
| 46 | Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia | Lipids in Health and Disease | 2020 | 12 |
| 47 | LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial | Atherosclerosis | 2021 | 11 |
| 48 | Management of Familial Hypercholesterolemia in Hong Kong | Journal of Atherosclerosis and Thrombosis | 2016 | 10 |
| 49 | Differences in Frame Geometry Between Balloon-expandable and Self-expanding Transcatheter Heart Valves and Association With Aortic Regurgitation | Revista Espanola De Cardiologia (English Ed ) | 2016 | 10 |
| 50 | The brave new world of genetic testing in the management of the dyslipidaemias | Current Opinion in Cardiology | 2020 | 10 |
